There are 121 papers on beta-amyloid in aging research: 2 trials and 64 observational studies in people, 17 in animals, 2 in cells, 35 reviews.
121 papers study it234 more mention it50 findings
7 new papers in 30 daysSee all 355 papers on beta-amyloid
At a glance
Beta-amyloid is linked with word-list memory decline in a human cohort, particularly after age 60, and faster mesial temporal tau accumulation in cognitively unimpaired, amyloid-positive adults. Other human studies report cognitive associations or no clear link; reviews describe beta-amyloid as a predictor of Alzheimer's disease at the preclinical stage.
50 findings in 40 papers from 2006 to 2026, 5 of them since June 2026
“Gene set enrichment and pseudo-time trajectories described extensive DNA double-strand breaks (DSBs), mitochondrial dysfunction and ER stress associated with increased β-amyloid leading to premature senescence in microglia.”
- Human trial2
- Humans64
- Animals17
- Cells2
Interventions
12Exercise
upin humans1downin mice1
2 studies
Exercise
upin humans1downin mice1
Exercise improves beta-amyloid in humans (APOE-ε4 allele carriers with Alzheimer's disease).
“Further benefits on cerebrospinal fluid beta-amyloid were also demonstrated in APOE-ε4 allele carriers with Alzheimer's disease.”
ReviewAPOE-ε4 allele carriers with Alzheimer's diseasecerebrospinal fluid
Does Physical Exercise Modify the Pathophysiology of Alzheimer's Disease in Older Persons?
JAR life
Exercise decreases beta-amyloid in experimental models of Alzheimer's disease (SMD -2.71, 95% CI -3.59 to -1.84).
“Meta-analysis demonstrated a decrease in Aβ with greater effect in unspecified isoforms (N = 4; SMD = -2.71, IC 95%: -3.59, -1.84, p < 0.00001, Q2 = 3.38, I2 = 11%)”
Reviewin experimental models of Alzheimer's disease
Experimental gerontology
Magnolia kobus
downin mice1
1 study
Magnolia kobus
downin mice1
Magnolia kobus decreases beta-amyloid in mice.
“lower β-amyloid-related immunoreactivity and p-Tau (Ser404) levels in the aged hippocampus”
Animalshippocampus
Journal of microbiology and biotechnology
Phytoestrogens
downin mice1
1 study
Phytoestrogens
downin mice1
Phytoestrogens decrease beta-amyloid in VCD-challenged mice.
“and decreased β-amyloid protein expression.”
Animalsin VCD-challenged micebrain
Naunyn-Schmiedeberg's archives of pharmacology
Arginine
downin rats1
1 study
Arginine
downin rats1
Arginine decreases beta-amyloid in aged rats with AD-induced choroid plexus changes (serum 67.40 vs 47.30; CSF 189.26 vs 169.84 pg/ml).
“decreased levels of TNF-α (86.63 vs 41.39 pg/ml) (p< 0.001), IL-1β (96.04 vs 39.57 pg/ml) (p< 0.001), Aβ (serum: 67.40 vs 47.30; CSF: 189.26 vs 169.84 pg/ml) (p< 0.001)”
Animalsin aged rats with AD-induced choroid plexus changesn = 7
Tissue & cell
Kaempferol
downin reviews1
1 study
Kaempferol
downin reviews1
Kaempferol decreases beta-amyloid.
“it hinders the formation and aggregation of beta-amyloid protein and regulates brain-derived neurotrophic factors”
Review
Kaempferol: Paving the path for advanced treatments in aging-related diseases
Experimental gerontology
Swimming
downin rats1
1 study
Swimming
downin rats1
Swimming decreases beta-amyloid in rats (aluminum chloride-induced Alzheimer's disease model; compared with non-exercised AD rats).
“Higher testosterone and lower GnRH, LH, FSH and β-amyloid levels, as well as cognitive improvement, were observed in the exercised compared to non-exercised AD rats”
Animalsaluminum chloride-induced Alzheimer's disease model; compared with non-exercised AD ratsswimming protocolhippocampus60 min/day, 5 days/week4 weeksmales
Effect of exercise on the hypothalamic-pituitary-gonadal axis in a rat model of Alzheimer's disease
Scientific reports
Resveratrol
downin reviews1
1 study
Resveratrol
downin reviews1
Resveratrol decreases beta-amyloid (via SIRT1-NF-κB-BACE1 signaling).
“reduced β-amyloid via SIRT1-NF-κB-BACE1 signaling”
Reviewvia SIRT1-NF-κB-BACE1 signaling
Sirtuins, resveratrol and the intertwining cellular pathways connecting them
Ageing research reviews
Streptozotocin
no changein rats1
1 study
Streptozotocin
no changein rats1
Streptozotocin showed no clear effect on beta-amyloid in rats.
“No significant difference was found in the cooperation (social cognition) and pairwise discrimination (visual memory) assays and hippocampal β-amyloid levels.”
Animalsintracerebroventricularly injectedhippocampus3 × 1.5 mg/kg3 months
Scientific reports
Regulatory peptides
downin reviews1
1 study
Regulatory peptides
downin reviews1
Regulatory peptides prevent beta-amyloid.
“prevent its accumulation in concentrations toxic to cells”
Review
Antioxidative properties of geroprotective peptides
Advances in gerontology = Uspekhi gerontologii
Anti-rage antibody
downin rats1
1 study
Anti-rage antibody
downin rats1
Anti-rage antibody decreases beta-amyloid in isoflurane-exposed aged rats.
“expression of RAGE and proinflammatory mediators, as well as, Aβ accumulation were attenuated”
Animalsin isoflurane-exposed aged rats
Anti-RAGE antibody attenuates isoflurane-induced cognitive dysfunction in aged rats
Behavioural brain research
All 12Fewer
Effects
6Study retention
downin humans1
1 study
Study retention
downin humans1
Beta-amyloid is linked with lower study retention in humans.
“Being β-amyloid positive (measures using positron emission tomography), female sex, and older age at baseline associated with lower odds of retention”
Humans2.5 yearsn = 502
BMC research notes
Neuronal Density Index
downin humans1
1 study
Neuronal Density Index
downin humans1
Beta-amyloid is linked with lower Neuronal Density Index in humans (Aβ(+) vs Aβ(-) (cutoff 1.42)).
“NDI significantly decreased in multiple brain regions, while significant volume changes were observed only in frontal and insular regions.”
HumansAβ(+) vs Aβ(-) (cutoff 1.42)multiple brain regions
AAIC 2025 abstract
Cellular senescence
upin humans1
1 study
Cellular senescence
upin humans1
Beta-amyloid is linked with cellular senescence in microglia, inferred from pseudo-time trajectories.
“Gene set enrichment and pseudo-time trajectories described extensive DNA double-strand breaks (DSBs), mitochondrial dysfunction and ER stress associated with increased β-amyloid leading to premature senescence in microglia.”
Humansin microglia, inferred from pseudo-time trajectoriesmicroglia
Acta neuropathologica
Sleep metrics
no changein humans1
1 study
Sleep metrics
no changein humans1
Beta-amyloid was not clearly linked with sleep metrics in humans (cognitively normal older adults).
“There were no Aβ-related differences in standard sleep or RAR metrics.”
Humanscognitively normal older adultsn = 82
Evaluating a novel 24-hour rest/activity rhythm marker of preclinical β-amyloid deposition
Sleep
Tau accumulation rate
upin humans1
1 study
Tau accumulation rate
upin humans1
Beta-amyloid is linked with higher tau accumulation rate in humans (cognitively unimpaired beta-amyloid positive (CU Aβ+)).
“In CU Aβ+, significantly higher rate of accumulation was seen in the MTL (particularly the amygdala), extending into the inferior temporal lobes.”
Humanscognitively unimpaired beta-amyloid positive (CU Aβ+)mesial temporal lobe1.48 years mediann = 44
EBioMedicine
Cognitive function
no changein humans1
1 study
Cognitive function
no changein humans1
Beta-amyloid was not clearly linked with cognitive function in humans.
“Aβ load had no relation to current cognitive function.”
Humans
Impact of lifestyle dimensions on brain pathology and cognition
Neurobiology of aging
Upstream
7Posttraumatic stress disorder
upin humans1
1 study
Posttraumatic stress disorder
upin humans1
Posttraumatic stress disorder is linked with higher beta-amyloid in humans (postmortem basolateral amygdala tissue).
“PTSD cases showed enrichment of combined tau-amyloid pathology within the basolateral amygdala and greater β-amyloid burden.”
Humanspostmortem basolateral amygdala tissuebasolateral amygdala
Neurobiology of aging
APOE
upin humans1
1 study
APOE
upin humans1
APOE is linked with higher beta-amyloid in ABI3S209F carriers (SUVR 2.0 (0.7) vs. 1.67 (0.5), p = 0.017).
“The carriers of ABI3S209F and APOE ε4 had higher brain Aβ burden when compared to the ABI3S209F carriers without APOE ε4 (SUVR 2.0 (0.7) vs. 1.67 (0.5); mean (sd), p = 0.017)”
Humansin ABI3S209F carriersn = 58
Alzheimer's research & therapy
ABI3
no changein humans1
1 study
ABI3
no changein humans1
ABI3 was not clearly linked with beta-amyloid in humans (cognitively healthy older adults) (1.67 (0.5) vs 1.75 (0.6), p = 0.75).
“there was no difference in Aβ between the ABI3S209F carriers and controls (1.67 (0.5) vs 1.75 (0.6), p = 0.75 (HST)).”
Humanscognitively healthy older adultsn = 58
Alzheimer's research & therapy
Framingham risk score
no changein humans1
1 study
Framingham risk score
no changein humans1
Framingham risk score was not clearly linked with beta-amyloid in humans.
“FRS was related to MRI measures, but not AD biomarkers.”
Humansn = 1,052
Alzheimer's & dementia : the journal of the Alzheimer's Association
Telomere length
downin humans1
1 study
Telomere length
downin humans1
Telomere length is linked with lower beta-amyloid in humans (beta = -0.15, p = 0.023).
“We found TL to be associated with β-amyloid levels (beta = - 0.15, p = 0.023)”
Humansdorsolateral prefrontal cortexn = 367
Evaluating genomic signatures of aging in brain tissue as it relates to Alzheimer's disease
Scientific reports
CD82
upin mice1
1 study
CD82
upin mice1
CD82 increases beta-amyloid in mice (overexpression; reversed by Numb T346S348 mutants).
“CD82 overexpression promoted beta-amyloid peptide (Aβ) secretion which could be reversed by Numb T346S348 mutants”
Animalsoverexpression; reversed by Numb T346S348 mutants
CD82-TRPM7-Numb signaling mediates age-related cognitive impairment
GeroScience
SIRT1
downin mouse cells1
1 study
SIRT1
downin mouse cells1
SIRT1 decreases beta-amyloid in mouse cells (manipulated in cultured mouse neurons).
“the predicted attenuation of beta-amyloid content in the brain during CR can be reproduced in mouse neurons in vitro by manipulating cellular SIRT1 expression/activity”
Cellsmanipulated in cultured mouse neuronsneurons
The Journal of biological chemistry
Associations
24Preclinical amyloid pathology
upin humans1
1 study
Preclinical amyloid pathology
upin humans1
Beta-amyloid is associated with preclinical amyloid pathology in humans (before clinical manifestations).
“The evidence discussed indicated the relevance of this biomarker in identifying changes related to amyloid pathology before the onset of clinical manifestations.”
Reviewbefore clinical manifestations
Beta-amyloid protein as a biomarker in the diagnosis of Alzheimer's disease
Revista Tópicos.
White matter hyperintensity accrual
upin humans1
1 study
White matter hyperintensity accrual
upin humans1
Beta-amyloid is associated with white matter hyperintensity accrual in humans (longitudinal studies; findings are not uniform and do not establish causation).
“Some longitudinal studies associate baseline Aβ with subsequent WMH accrual, but findings are not uniform and do not establish causation.”
Reviewlongitudinal studies; findings are not uniform and do not establish causationbrain white matter
Frontiers in aging neuroscience
Synaptic Dysfunction Index
upin humans1OR 16.65
1 study
Synaptic Dysfunction Index
upin humans1OR 16.65
Beta-amyloid is associated with Synaptic Dysfunction Index in humans (OR: 16.65; IC 95%: 3.80-72.87).
“The presence of beta-amyloid was associated with a higher IDsyn (p < 0.001), especially at elevated values (OR: 16.65; IC 95%: 3.80-72.87).”
Humansn = 375
Archivos de Neurociencias
Alzheimer's disease
upin humans1
1 study
Alzheimer's disease
upin humans1
Beta-amyloid predicts Alzheimer's disease in humans (preclinical stage).
“βA is an important biomarker for early detection of DA.”
Reviewpreclinical stage
Biomarkers for early detection of Alzheimer's disease
Tudo é Ciência.
IRS-1 pS616
upin humans1
1 study
IRS-1 pS616
upin humans1
IRS-1 pS616 is associated with beta-amyloid in humans.
“IRS‐1 pS616 pathology was positively correlated with β‐amyloid pathology”
Humanshippocampal CA1
AAIC 2025 abstract
Neuronal Density Index
downin humans1
1 study
Neuronal Density Index
downin humans1
Beta-amyloid is associated with Neuronal Density Index in humans (mcSUVr < 1.2 vs 1.2-1.6).
“NDI exhibited significant changes in medial temporal lobe even when comparing groups with mcSUVr < 1.2 and mcSUVR between 1.2 and 1.6”
HumansmcSUVr < 1.2 vs 1.2-1.6medial temporal lobe
AAIC 2025 abstract
G-CSF
downin humans1
1 study
G-CSF
downin humans1
G-CSF is associated with beta-amyloid in humans (β = -0.14, 95% CI -0.19 to -0.09).
“Elevated blood G-CSF levels were inversely related to β-amyloid levels”
Humanscerebrospinal fluid
Cytokine
Mild behavioral impairment
upin humans1
1 study
Mild behavioral impairment
upin humans1
Beta-amyloid is associated with mild behavioral impairment in older adults.
“correlates predominantly classified into three categories: (1) neurocognitive factors such as beta-amyloid and tau protein”
Reviewin older adults
Correlates of mild behavioural impairment in older adults: a scoping review
BMC geriatrics
General fitness
upin humans1
1 study
General fitness
upin humans1
Beta-amyloid is associated with general fitness in humans (cognitively healthy ageing).
“Moreover, it was associated with either higher cognitive performance, general fitness, cerebral tissue integrity and cerebral perfusion, or had no discernible impact.”
Humanscognitively healthy ageingbrainn = 35
Journal of neurochemistry
Cognitive function
upin humans1
1 study
Cognitive function
upin humans1
Beta-amyloid is associated with cognitive function in humans (cognitively healthy ageing).
“Moreover, it was associated with either higher cognitive performance, general fitness, cerebral tissue integrity and cerebral perfusion, or had no discernible impact.”
Humanscognitively healthy ageingbrainn = 35
Journal of neurochemistry
All 24Fewer
Funding
28 grants since 2016National Institute on Aging$21MNational Institute of Mental Health$3.4MJapan Society for the Promotion of Science¥9.1M
Dysregulation of Cav1.2 by beta amyloid peptide
National Institute on AgingUniversity of California at Davis$539K2016–2027
National Institute on AgingBoston University Medical Campus$784K2023–2028
National Institute on AgingBoston University Medical Campus$558K2021–2027
Imaging Beta-Amyloid Clearance Mechanisms in the Aging Brain
National Institute on AgingUniversity of Pittsburgh at Pittsburgh$587K2022–2028
Vitamin D and beta-amyloid signaling in hyperparathyroidism
National Institute on AgingUniversity of California, San Francisco$757K2023–2028
Novel Extracorporeal Device 'Amytrapper' To Remove Beta Amyloid In Alzheimer'sDisease
National Institute on AgingRecombinant Technologies$625K2017–2027
European CommissionUniversidade Nova de Lisboa€191K2025–2027
Gouvernement du Canada | Canadian Institutes of Health ResearchUniversity of WaterlooCA$27K2024–2025
National Institute on AgingUniversity of Southern California$28.1K2019–2025
Effects of Acute Stress Exposure on Plasma beta-amyloid Levels
National Institute on AgingUniversity of Southern California$255K2022–2025
How this record changed
Summary written from the findings.